How to Help Your Patients Find Urocit-K XR in Stock: A Provider's Guide

Kidney stone disease has a recurrence rate of up to 50% within five years without preventive therapy. For patients with hypocitraturia, uric acid lithiasis, or renal tubular acidosis, potassium citrate extended release (Urocit-K XR) is a cornerstone of long-term prevention. When patients can't fill their prescriptions, they're at real risk. This guide gives clinicians concrete, low-overhead tools to help patients locate their medication and stay on therapy.

Why Are Patients Struggling to Fill Urocit-K XR?

The challenges are not due to a formal FDA shortage — potassium citrate ER is not on the FDA's drug shortage list as of 2026. Instead, patients encounter localized stocking gaps: pharmacies that don't carry all three strengths (5, 10, and 15 mEq), brand vs. generic inventory mismatches, and occasional distributor delays. The 15 mEq strength is most commonly reported as unavailable. Patients are often surprised to learn that a phone call to a different pharmacy or a switch to generic can solve the problem instantly.

Prescribing Practices That Improve Fill Rates

Use the generic name. Prescribe "potassium citrate extended release" rather than "Urocit-K." Generic versions are FDA-approved, therapeutically equivalent, and more reliably stocked than the brand.

Allow strength flexibility. Adding a note like "may substitute equivalent strengths" enables pharmacists to fill the prescription with available tablets. For example, two 10 mEq tablets can replace one 20 mEq dose, or three 5 mEq tablets can replace a 15 mEq dose.

Prescribe 90-day supplies via mail-order. Mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) typically maintain better inventory than retail pharmacies and offer cost savings for maintenance medications.

Avoid DAW (Dispense As Written) unless clinically necessary. DAW codes prevent generic substitution and significantly limit pharmacy options. Use DAW only if there's a specific clinical reason to require the brand.

Tools to Share with Patients Searching for Urocit-K XR

medfinder.com: Calls pharmacies near the patient to check which ones have Urocit-K XR in stock and can fill the prescription. Patients receive results by text. This eliminates the need for patients to call pharmacies themselves — reducing patient frustration and reducing callbacks to your office.

GoodRx.com: Shows pharmacy pricing and can indicate which pharmacies stock the medication. Generic potassium citrate ER costs as little as $13–$15 with a GoodRx coupon.

Insurance pharmacy portal: Most commercial insurance websites have a pharmacy locator that shows in-network pharmacies with formulary coverage — helpful for patients who want the lowest copay.

What to Tell Patients Who Miss Doses During a Supply Gap

Advise patients on the following in the event of a brief supply gap:

Maximize fluid intake — at least 2 liters of water per day to dilute urine and reduce crystallization risk.

Reduce sodium intake — high urinary sodium promotes calcium excretion, increasing calcium stone risk.

Increase dietary citrate — lemon juice (4 oz/day diluted in water) can modestly raise urinary citrate.

Contact your provider after a gap of > 7 days — especially for RTA patients who may need monitoring of serum bicarbonate and potassium.

Documentation and Aftercare Tips

A brief note in your after-visit summary pointing patients to medfinder or GoodRx can significantly reduce pharmacy-related callbacks to your office. Consider adding a standard line to your discharge instructions for all patients on potassium citrate therapy: "If you have trouble filling this prescription, you can use medfinder.com or GoodRx.com to find which pharmacies near you have it in stock."

For practice-level resources, visit medfinder for providers. For a guide to savings programs to share with patients, see our post on

how to help your patients save money on Urocit-K XR.